Clorox (NYSE:CLX) Price Target Lowered to $169.00 at DA Davidson

Clorox (NYSE:CLX) had its price objective cut by DA Davidson from $171.00 to $169.00 in a research note published on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock.

Other equities analysts have also issued reports about the company. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Wells Fargo & Company increased their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday. Finally, Barclays dropped their price target on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus target price of $158.21.

Clorox Price Performance

Shares of NYSE CLX opened at $145.98 on Wednesday. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The firm has a market capitalization of $18.07 billion, a PE ratio of 50.86, a P/E/G ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The business’s fifty day moving average price is $162.25 and its two-hundred day moving average price is $158.76.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the prior year, the firm posted $2.16 EPS. On average, research analysts expect that Clorox will post 6.86 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.04%.

Institutional Investors Weigh In On Clorox

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Mizuho Securities USA LLC increased its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP increased its position in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after acquiring an additional 453,624 shares in the last quarter. International Assets Investment Management LLC raised its holdings in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares during the period. Boston Trust Walden Corp lifted its position in shares of Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after acquiring an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after purchasing an additional 265,455 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.